Novartis confirms 9 reported cases of tumors linked to spinal muscular atrophy therapy Zolgensma

Advocates are sounding the alarm on social media as they learn from their doctors that Novartis has received reports of tumors in patients who have been treated with the spinal muscular atrophy gene therapy.